Genetics and epigenetics in the neurodegenerative disorders of the central nervous system

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Most of the neurodegenerative diseases share several clinical, pathologic, and molecular aspects. Clinically, these diseases are often characterized by an insidious onset during adulthood, after which they progress at different rates, ultimately leading to severe physical disability or death. The symptoms are often common among the different disorders: dementia is not only peculiar of Alzheimer’s disease (AD) or frontotemporal dementia (FTD), but could occur also in Parkinson’s disease (PD) or amyotrophic lateral sclerosis (ALS). Furthermore, under a genetic point of view, many neurodegenerative diseases manifest an important family history, highlighting a relevant contribution of genetic factors to disease causation and progression. Genetics and epigenetics, together with their new designed technologies capable of analyzing genetic variability, have disclosed an appealing scenario that will offer the biomedical sciences new insight for the study of neurodegenerative diseases, multifactorial complex, and rare diseases. In this chapter, an overview of the current genetic and epigenetic progresses in AD, FTD, PD, and ALS, reached by the application of the new genetic technologies, will be provided.

Original languageEnglish
Title of host publicationNeurodegeneratIve Diseases
Subtitle of host publicationClinical Aspects, Molecular Genetics and Biomarkers
PublisherSpringer International Publishing AG
Pages1-20
Number of pages20
ISBN (Electronic)9783319729381
ISBN (Print)9783319729374
DOIs
Publication statusPublished - Jan 1 2018

Fingerprint

Neurology
Epigenomics
Neurodegenerative Diseases
Frontotemporal Dementia
Alzheimer Disease
Central Nervous System
Amyotrophic Lateral Sclerosis
Neurodegenerative diseases
Parkinson Disease
Technology
Rare Diseases
Causality
Dementia
Disease Progression
Genetics

Keywords

  • Alzheimer’s disease
  • Amyotrophic lateral sclerosis
  • Epigenetics
  • Frontotemporal dementia
  • Genetics
  • Parkinson’s disease

ASJC Scopus subject areas

  • Medicine(all)
  • Neuroscience(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Fenoglio, C. (2018). Genetics and epigenetics in the neurodegenerative disorders of the central nervous system. In NeurodegeneratIve Diseases: Clinical Aspects, Molecular Genetics and Biomarkers (pp. 1-20). Springer International Publishing AG. https://doi.org/10.1007/978-3-319-72938-1_1

Genetics and epigenetics in the neurodegenerative disorders of the central nervous system. / Fenoglio, Chiara.

NeurodegeneratIve Diseases: Clinical Aspects, Molecular Genetics and Biomarkers. Springer International Publishing AG, 2018. p. 1-20.

Research output: Chapter in Book/Report/Conference proceedingChapter

Fenoglio, C 2018, Genetics and epigenetics in the neurodegenerative disorders of the central nervous system. in NeurodegeneratIve Diseases: Clinical Aspects, Molecular Genetics and Biomarkers. Springer International Publishing AG, pp. 1-20. https://doi.org/10.1007/978-3-319-72938-1_1
Fenoglio C. Genetics and epigenetics in the neurodegenerative disorders of the central nervous system. In NeurodegeneratIve Diseases: Clinical Aspects, Molecular Genetics and Biomarkers. Springer International Publishing AG. 2018. p. 1-20 https://doi.org/10.1007/978-3-319-72938-1_1
Fenoglio, Chiara. / Genetics and epigenetics in the neurodegenerative disorders of the central nervous system. NeurodegeneratIve Diseases: Clinical Aspects, Molecular Genetics and Biomarkers. Springer International Publishing AG, 2018. pp. 1-20
@inbook{183e2b9f35364d70825286e63c98d4cd,
title = "Genetics and epigenetics in the neurodegenerative disorders of the central nervous system",
abstract = "Most of the neurodegenerative diseases share several clinical, pathologic, and molecular aspects. Clinically, these diseases are often characterized by an insidious onset during adulthood, after which they progress at different rates, ultimately leading to severe physical disability or death. The symptoms are often common among the different disorders: dementia is not only peculiar of Alzheimer’s disease (AD) or frontotemporal dementia (FTD), but could occur also in Parkinson’s disease (PD) or amyotrophic lateral sclerosis (ALS). Furthermore, under a genetic point of view, many neurodegenerative diseases manifest an important family history, highlighting a relevant contribution of genetic factors to disease causation and progression. Genetics and epigenetics, together with their new designed technologies capable of analyzing genetic variability, have disclosed an appealing scenario that will offer the biomedical sciences new insight for the study of neurodegenerative diseases, multifactorial complex, and rare diseases. In this chapter, an overview of the current genetic and epigenetic progresses in AD, FTD, PD, and ALS, reached by the application of the new genetic technologies, will be provided.",
keywords = "Alzheimer’s disease, Amyotrophic lateral sclerosis, Epigenetics, Frontotemporal dementia, Genetics, Parkinson’s disease",
author = "Chiara Fenoglio",
year = "2018",
month = "1",
day = "1",
doi = "10.1007/978-3-319-72938-1_1",
language = "English",
isbn = "9783319729374",
pages = "1--20",
booktitle = "NeurodegeneratIve Diseases",
publisher = "Springer International Publishing AG",
address = "Switzerland",

}

TY - CHAP

T1 - Genetics and epigenetics in the neurodegenerative disorders of the central nervous system

AU - Fenoglio, Chiara

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Most of the neurodegenerative diseases share several clinical, pathologic, and molecular aspects. Clinically, these diseases are often characterized by an insidious onset during adulthood, after which they progress at different rates, ultimately leading to severe physical disability or death. The symptoms are often common among the different disorders: dementia is not only peculiar of Alzheimer’s disease (AD) or frontotemporal dementia (FTD), but could occur also in Parkinson’s disease (PD) or amyotrophic lateral sclerosis (ALS). Furthermore, under a genetic point of view, many neurodegenerative diseases manifest an important family history, highlighting a relevant contribution of genetic factors to disease causation and progression. Genetics and epigenetics, together with their new designed technologies capable of analyzing genetic variability, have disclosed an appealing scenario that will offer the biomedical sciences new insight for the study of neurodegenerative diseases, multifactorial complex, and rare diseases. In this chapter, an overview of the current genetic and epigenetic progresses in AD, FTD, PD, and ALS, reached by the application of the new genetic technologies, will be provided.

AB - Most of the neurodegenerative diseases share several clinical, pathologic, and molecular aspects. Clinically, these diseases are often characterized by an insidious onset during adulthood, after which they progress at different rates, ultimately leading to severe physical disability or death. The symptoms are often common among the different disorders: dementia is not only peculiar of Alzheimer’s disease (AD) or frontotemporal dementia (FTD), but could occur also in Parkinson’s disease (PD) or amyotrophic lateral sclerosis (ALS). Furthermore, under a genetic point of view, many neurodegenerative diseases manifest an important family history, highlighting a relevant contribution of genetic factors to disease causation and progression. Genetics and epigenetics, together with their new designed technologies capable of analyzing genetic variability, have disclosed an appealing scenario that will offer the biomedical sciences new insight for the study of neurodegenerative diseases, multifactorial complex, and rare diseases. In this chapter, an overview of the current genetic and epigenetic progresses in AD, FTD, PD, and ALS, reached by the application of the new genetic technologies, will be provided.

KW - Alzheimer’s disease

KW - Amyotrophic lateral sclerosis

KW - Epigenetics

KW - Frontotemporal dementia

KW - Genetics

KW - Parkinson’s disease

UR - http://www.scopus.com/inward/record.url?scp=85046590407&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046590407&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-72938-1_1

DO - 10.1007/978-3-319-72938-1_1

M3 - Chapter

AN - SCOPUS:85046590407

SN - 9783319729374

SP - 1

EP - 20

BT - NeurodegeneratIve Diseases

PB - Springer International Publishing AG

ER -